The role Infarmed plays within the European regulatory network was highlighted by the EMA during an official visit to Portugal. This recognition stems from the high quality of Infarmed’s work, as well as its expertise and strong commitment to European cooperation.

This prominent position reinforces Portugal’s status as a gateway for Brazilian and Latin American companies seeking to enter the European market; a shared language, regulatory alignment, and Infarmed’s technical standing within the EMA network facilitate this process.

Vita operates in Portugal, handling the preparation and submission of dossiers to Infarmed, local regulatory representation, outsourced pharmacovigilance, market access support, and assistance with applications for a Certificate of Suitability (CEP) from the EDQM. Companies interested in exploring the European market via Portugal can rely on Vita to design this strategy.